Specializes in Genitourinary Oncology, Prostate Cancer and Urology
Jue Wang, MD, FACP, is the Section Leader of the Genitourinary Oncology Division at Dignity Health Cancer Institute. Dr. Wang’s primary expertise is in the personalized treatment of genitourinary tumors, which includes cancers of the urinary tract and male genital tract, including prostate, bladder, kidney, testicular, urethral and penile cancer. Dr. Wang’s research focuses on improving the effectiveness of cancer treatment by incorporating target and immunotherapy into the treatment of chemotherapy resistant genitourinary cancers. He has conducted clinical trials focus on genitourinary precision oncology. Dr. Wang has served on national organizations such as National Comprehensive Cancer Network (NCCN) clinical practice guideline Committees. He serves as editor in chief, as well as on the editorial boards of numerous academic journals and has more than 100 peer-reviewed publications and book chapters. Dr. Wang has been recognized as Castle Connolly Top Doctor in the specialty of Medical Oncology in 2014, 2015, 2016, 2017, 2018. He is Professor of Medicine, Creighton School of Medicine and Professor of Medicine, University of Arizona College of Medicine – Phoenix, Department of Internal Medicine and Department of Interdisciplinary Oncology.
I believe cancer treatment must be delivered with compassionate care, humaneness, and love. I strive to provide each cancer patient with individualized, gender-specific, patient-centered care that is tailor-made for every patient.”Jue Wang, MD